Close Menu

Sema4, a Mount Sinai genomic testing spinout, plans to relocate its laboratory facilities from New York to a yet-to-be-determined site in Stamford, Connecticut, and will add more than 400 jobs over the next five years. The new Stamford lab will complement the company's existing recently announced headquarters in Stamford and its laboratory in Branford, Connecticut. Overall, Sema4 is expected to employ more than 550 employees in the state.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.